Christopher S Rogers,
Yanhong Hao,
Tatiana Rokhlina,
Melissa Samuel,
David A Stoltz,
Yuhong Li, Elena Petroff,
Daniel W Vermeer,
Amanda C Kabel,
Ziying Yan,
Lee Spate,
David Wax,
Clifton N Murphy,
August Rieke,
Kristin Whitworth,
Michael L Linville,
Scott W Korte,
John F Engelhardt,
Michael J Welsh,
Randall S Prather
[show abstract]
[hide abstract]
ABSTRACT: Progress toward understanding the pathogenesis of cystic fibrosis (CF) and developing effective therapies has been hampered by lack of a relevant animal model. CF mice fail to develop the lung and pancreatic disease that cause most of the morbidity and mortality in patients with CF. Pigs may be better animals than mice in which to model human genetic diseases because their anatomy, biochemistry, physiology, size, and genetics are more similar to those of humans. However, to date, gene-targeted mammalian models of human genetic disease have not been reported for any species other than mice. Here we describe the first steps toward the generation of a pig model of CF. We used recombinant adeno-associated virus (rAAV) vectors to deliver genetic constructs targeting the CF transmembrane conductance receptor (CFTR) gene to pig fetal fibroblasts. We generated cells with the CFTR gene either disrupted or containing the most common CF-associated mutation (DeltaF508). These cells were used as nuclear donors for somatic cell nuclear transfer to porcine oocytes. We thereby generated heterozygote male piglets with each mutation. These pigs should be of value in producing new models of CF. In addition, because gene-modified mice often fail to replicate human diseases, this approach could be used to generate models of other human genetic diseases in species other than mice.
Journal of Clinical Investigation 05/2008; 118(4):1571-7. · 15.39 Impact Factor
